Wize Pharma Eulerpool News

Wize Pharma Stock News

Wize Pharma is being monitored by journalists and investors worldwide. We gather the latest Wize Pharma news here.

Wize Pharma Stock Press Releases

Wize Pharma regularly publishes news on the company's website that are relevant for investors.

Wize Pharma News 2026

This page contains all current news, analysis and press releases for Wize Pharma stock (WIZP, ISIN: US97751M2070). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Wize Pharma.

Wize Pharma Stock

Wize Pharma Wize Pharma Inc. is a leading biopharmaceutical company specializing in the development and marketing of innovative products for the treatment of eye diseases. The company was founded in 1997 and is headquartered in Herzliya Pituach, Israel. It focuses on the research, development, manufacturing, and marketing of eye disease treatments. The company aims to become a leading brand in the field of eye health and offers high-quality services in eye care. Wize Pharma Inc. operates different divisions, with its main divisions being the development and marketing of eye therapeutics, including LO2A and LO2B. LO2A is an innovative therapy for dry eye, while LO2B is an intraoperative formulation used in glaucoma surgery. The company's products provide effective and sustainable solutions for the treatment of eye diseases.